2026 MIPS Measures Relevant to Hospitalists

+

ID: 5 NQF: 81 eMeasure ID: CMS135v14

2026 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction…

Read more

+

ID: 8 NQF: 83 eMeasure ID: CMS144v14

2026 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction…

Read more

+

ID: 47 NQF: 326 eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #47: Advance Care Plan

Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or…

Read more

+

ID: 130 NQF: None eMeasure ID: CMS68v15 ✹ High Priority: Yes

2026 MIPS Measure #130: Documentation of Current Medications in the Medical Record

Percentage of visits for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date…

Read more